In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

A new chapter for Jewish life at the University of Nevada, Reno through Chabad Rabbi Dani Libersohn leads Chabad at the University, sharing insights, community building and what’s next for Chabad ...

Investing in pharmaceutical stocks offers dividends and growth from a $2 trillion market. Eli Lilly leads in market cap, with promising drugs in obesity and diabetes treatment. Pfizer, despite ...